Phenadoxone

This classification denotes an opioid receptor agonist and opioid with the molecular formula C23H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 375W3TA42N, chemically known as 4,4-diphenyl-6-morpholino-3-heptanone but generally known as phenadoxone, which bears US NIH Compound Identifier 10089. European Medicines Agency schedules Phenadoxone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09747MIG. The term PHENADOXONE is an International Non-Proprietary Name. PHENADOXONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phenadoxone under HS 29349990 and SITC 51579. As of Q4 2014, PHENADOXONE remains the US FDA Preferred Term for this commodity. Phenadoxone bears US NLM identifiers UMLS ID C1882360 and NCI Concept Code C66364. SMILES: O1CCN(C(CC(C2CCCCC2)(C2CCCCC2)C(=O)CC)C)CC1.